Autoimmune & Inflammatory
Also called GPA, Wegener's Granulomatosis
Granulomatosis with Polyangiitis is a systemic necrotizing vasculitis affecting small and medium blood vessels, characterized by the triad of granulomatous inflammation, necrotizing vasculitis, and glomerulonephritis. The disease results from ANCA-associated immune mechanisms, with most patients positive for c-ANCA (anti-PR3 antibodies).
Granulomatosis with Polyangiitis can develop at any age but typically manifests in the fourth to sixth decades of life, with bimodal distribution peaking in the 50s-60s and with some pediatric cases. It affects males and females roughly equally. The disease occurs across all racial and ethnic groups, though higher prevalence noted in Caucasian populations. About 90% of patients with systemic GPA are c-ANCA/PR3 positive.
Clinical trials for Granulomatosis with Polyangiitis focus on induction and maintenance therapy optimization, particularly examining alternatives to cyclophosphamide (including rituximab), and exploring biologic therapies targeting B cells, T cells, and complement. Trials investigate corticosteroid-sparing regimens and strategies to prevent relapses while minimizing cumulative drug toxicity. Maintenance therapy with rituximab or azathioprine after induction has improved outcomes and reduced relapse rates. Patients should consult with a rheumatologist or nephrologist experienced in ANCA vasculitis.
Takayasu Arteritis is a rare chronic inflammatory disease of large arteries, particularly the aorta and its branches, ca...
Giant Cell Arteritis is a rare inflammatory disease of large and medium-sized arteries, primarily affecting people over ...
Behçet Disease is a rare, chronic, recurrent vasculitis causing painful oral and genital ulcers, eye inflammation, and s...